Temporary payment rule for certain drugs and biologicals
In the case of a drug or biological whose period of pass-through status under this paragraph ended on December 31, 2017 , and for which payment under this subsection was packaged into a payment for a covered OPD service (or group of services) furnished beginning January 1, 2018 , the payment amount for such drug or biological under this subsection that is furnished during the period beginning on October 1, 2018 , and ending on March 31, 2019 , shall be the greater of—
(i)#
the payment amount that would otherwise apply under subparagraph (D)(i) for such drug or biological during such period; or
(ii)#
the payment amount that applied under such subparagraph (D)(i) for such drug or biological on December 31, 2017 .